Skip to main content
Cancer Medicine logoLink to Cancer Medicine
. 2018 Jun 20;7(6):2792. doi: 10.1002/cam4.1593

Corrigendum

PMCID: PMC6010896  PMID: 29924501

Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11 348 patients

Ari Vanderwalde, David Spetzler, Nianqing Xiao, Zoran Gatalica & John Marshall

Cancer Medicine 2018; 7: 746‐756

The published version of Figure 2E coloration of this article was incorrect. The correct Figure 2 is shown below:

graphic file with name CAM4-7-2792-g001.jpg

The corresponding author apologizes for this error.

Vanderwalde A, Spetzler D, Xiao N, Gatalica Z, Marshall J. Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11 348 patients. Cancer Med. 2018;7:746‐756.


Articles from Cancer Medicine are provided here courtesy of Wiley

RESOURCES